Navigation Links
Omeros Files Clinical Trial Application for Lead Antibody in MASP-2 Program
Date:5/28/2013

SEATTLE, Wash., May 28, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has filed a Clinical Trial Application (CTA) with European regulators to initiate clinical trials evaluating OMS721, the Company's lead human monoclonal antibody from its mannan-binding lectin-associated serine protease-2 (MASP-2) program. The lead indication for OMS721 will be atypical hemolytic uremic syndrome (aHUS), a rare but life-threatening form of thrombotic microangiopathy (TMA). Assuming positive regulatory review of its CTA, Omeros plans to initiate a Phase 1 clinical trial evaluating OMS721 early next quarter.

The Phase 1 clinical trial will be a placebo-controlled, double-blind, single-ascending-dose study to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of OMS721 administered subcutaneously in healthy subjects. Immediately following this study, Omeros plans to advance OMS721 into a Phase 2 clinical trial in aHUS patients.

Omeros controls the worldwide rights to MASP-2 and all therapeutics targeting MASP-2, a novel pro-inflammatory protein involved in activation of the complement system – an important component of the immune system. The complement system plays a role in the inflammatory response to tissue damage or microbial infection. OMS721 selectively inhibits MASP-2, blocking the lectin pathway of the complement system while leaving intact the classical pathway, which represents the acquired immune response to infection. Soliris® (eculizumab), the only approved complement-targeting antibody on the market and the only currently approved therapy for aHUS, inhibits microbial killing by the classical pathway, increasing the risk of infection for the patient. By targeting only the lectin pathway and leaving the classical pathway intact, OMS721 should not have this increased infect
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros Corporation Reports First Quarter 2013 Financial Results
2. Omeros Announces $16.2 Million Registered Direct Offering of Common Stock
3. Omeros Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review
4. Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress
5. Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
6. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
7. Omeros Announces Positive OMS721 Data in Model of Thrombotic Microangiopathy
8. Omeros to Present at the 2013 Future Leaders in the Biotech Industry Conference
9. Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
10. Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
11. Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014  MiMedx Group, Inc.  ... processor and marketer of patent-protected regenerative biomaterials and ... it has filed its initial Investigational New Drug ... ("FDA").   The IND submission, which ... Company,s initial submission for certain indications of its ...
(Date:7/23/2014)... , July 23, 2014 ... of the "Prepackaged Medical Kits and Trays ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... markets for Prepackaged Medical Kits and Trays in ... Custom Trays, Ophthalmic Custom Trays, Custom Basin Kits, ...
(Date:7/23/2014)... , July 23, 2014 Sinovac Biotech Ltd. (NASDAQ: ... in China , announced today that it ... and Prevention ("Beijing CDC") to be a supplier of the ... for 2014. The Beijing CDC plans ... seasonal flu vaccine this year from four domestic vaccine manufacturers ...
Breaking Medicine Technology:MiMedx Files Its Initial Investigational New Drug Application 2MiMedx Files Its Initial Investigational New Drug Application 3Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu 2
... Feb. 16, 2011 New Mexico ... ), a developer of medical IT services and solutions that ... today the company will begin providing second opinion teleradiology interpretation ... "There is a solid market for patients and their families ...
... Fla., Feb. 16, 2011 One of America,s two largest ... pharmacy counters in nearly 3,000 stores.   To ... giving away through March 4 thousands of its bullet-shaped nasal ... bacteria.  Visit www.germbullet.com . "If you are ...
Cached Medicine Technology:New Mexico Software Initiates Medical Second Opinion Service via Telemedicine for Remote Consultation Review 2New Mexico Software Initiates Medical Second Opinion Service via Telemedicine for Remote Consultation Review 3Which Pharmacy Chain Offers GermBullet® Inhaler to Fight Exposure to Cold and Flu Viruses and Bacteria? 2
(Date:7/23/2014)... MA (PRWEB) July 23, 2014 ... technologies, the leasing and financing company LeaseQ announced ... the server based software sector, they still see ... , To learn more about technology equipment ... Founder and CEO of LeaseQ was quoted as ...
(Date:7/23/2014)... 2014 Splashtop , a ... that it has joined the RSA Ready Technology ... Enterprise and RSA SecurID® multi-factor authentication solution from ... , Splashtop also announced that leading Japanese ... Splashtop Enterprise, the industry’s only on-premise remote access ...
(Date:7/23/2014)... for the first time to call for better screening ... suffering from the condition. , Psoriatic arthritis (PsA) causes ... if left untreated. , PsA tends to affect people ... scaly rash, and affects approximately two per cent of ... five go on to develop PsA usually within ...
(Date:7/23/2014)... 23, 2014 On July 21, 2014, My ... advocate Jack Tracey for an episode that spoke about the ... Deierlein asks Tracey to talk some about the formation of ... its mission, it was started right here in Charleston, originally ... was to help survivors of sexual abuse. Their purpose has ...
(Date:7/23/2014)... Psoriasis is an autoimmune disease that is ... skin—but this disease is not just skin deep. It ... cancers, certain types of arthritis, or ulcerative colitis. Psoriasis ... occurs in families and is not contagious. It also ... must be managed at all times to relieve pain ...
Breaking Medicine News(10 mins):Health News:LeaseQ Announces That Although Software Investment Remains Sluggish, Technology Equipment Leasing Demand Remains Robust 2Health News:LeaseQ Announces That Although Software Investment Remains Sluggish, Technology Equipment Leasing Demand Remains Robust 3Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 3Health News:Psoriatic arthritis patients need better screening, warns panel of experts 2Health News:My Positive Perspective Airs Episode to Raise Attention to the Group Darkness to Light 2Health News:MedicationDiscountCard.com Makes Tazorac Discount Cards For Psoriasis Sufferers 2
... appear to have a lower risk of asthma than ... non-agricultural rural environment, according to a University of Alberta ... asthmafree children aged less than 12 years in the ... (NLSCY) showed that children living in a farming environment ...
... seventh,consecutive year West Coast Bank will partner with other ... of Doernbecher Auction, which,has raised over $2.5 million for ... will be held at Portland Art Museum, October 20, ... Vice President of Commercial Banking Xandra,McKeown serves as President ...
... detection of breast,cancer can mean the difference between life ... detection and treatment for breast,cancer, Sutter Solano Cancer Center ... the importance of screening and to make,them aware of ... National Breast Cancer Awareness Month, a free breast cancer,lecture ...
... The Cosmetic Bootcamp,LLC is pleased to announce that its ... meeting, has become the de facto leader,not only in ... one of the prime sources of information for venture ... mentioned that the,meeting and its relevance to the investment ...
... Oct. 16 STAAR Surgical,Company (Nasdaq: STAA ... for the third quarter ended September 29, 2007 ... The Company will host a conference call,and webcast ... Eastern Time to,discuss the Company,s third quarter and ...
... never,guessed that some of the best advertising for the ... Parenthood, the largest,abortion chain in the United States," said ... "People in more than 80 communities are taking ... the vigils are being conducted outside Planned,Parenthood facilities," he ...
Cached Medicine News:Health News:Farm kids have lower risk of asthma, study shows 2Health News:West Coast Bank Will Sponsor the Heart of Doernbecher Auction at the Portland Art Museum, October 20, 2007 2Health News:Sutter Solano Cancer Center Offers Advice, Free Lecture During Breast Cancer Awareness Month 2Health News:Sutter Solano Cancer Center Offers Advice, Free Lecture During Breast Cancer Awareness Month 3Health News:STAAR Surgical Announces Third Quarter 2007 Earnings Release Date and Conference Call 2Health News:40 Days for Life Reaches Halfway Point; Planned Parenthood Now in Crisis Mode 2
... Forma 1400 Series ... specifically to revolutionize working ... cabinet. The most comfortable, ... Class II cabinet on ...
... The Premier 12 Holter Analysis Kit incorporates ... Dispersion with other powerful DMS Holter analysis ... TWA analysis possible in less than 10 ... TWA, for visual verification and validation. The ...
... Designed for ease of use and patient ... smooth edges for comfort and is available ... to a perfect fit. For hard to ... trach collar to your specifications. Don't just ...
... more comfortable, and you will too., ... and to avoid the knotty problems associated ... ties, consider the Dale® Tracheostomy Tube Holder. ... narrow fastener tabs of the Dale® Tracheostomy ...
Medicine Products: